TMED vs. XHS
TMED (T. Rowe Price Health Care ETF) and XHS (SPDR S&P Health Care Services ETF) are both Health & Biotech Equities funds. A 0.57 correlation means they provide meaningful diversification when combined. TMED charges 0.44%/yr vs 0.35%/yr for XHS.
Performance
TMED vs. XHS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TMED achieves a 3.87% return, which is significantly lower than XHS's 6.32% return.
TMED
- 1D
- 1.04%
- 1M
- 2.47%
- YTD
- 3.87%
- 6M
- 4.17%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
XHS
- 1D
- 0.28%
- 1M
- 2.77%
- YTD
- 6.32%
- 6M
- 5.39%
- 1Y
- 16.58%
- 3Y*
- 8.47%
- 5Y*
- 0.44%
- 10Y*
- 7.46%
TMED vs. XHS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
TMED T. Rowe Price Health Care ETF | 3.87% | 18.92% |
XHS SPDR S&P Health Care Services ETF | 6.32% | 9.85% |
Correlation
The correlation between TMED and XHS is 0.57, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jun 13, 2025 | 0.57 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TMED vs. XHS — Risk / Return Rank
TMED
XHS
TMED vs. XHS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and SPDR S&P Health Care Services ETF (XHS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| TMED | XHS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 0.95 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.02 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.33 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.35 | 0.57 | +0.79 |
Drawdowns
TMED vs. XHS - Drawdown Comparison
The maximum TMED drawdown since its inception was -11.11%, smaller than the maximum XHS drawdown of -39.32%. Use the drawdown chart below to compare losses from any high point for TMED and XHS.
Loading charts...
Drawdown Indicators
| TMED | XHS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -11.11% | -39.32% | +28.21% |
Max Drawdown (1Y)Largest decline over 1 year | — | -11.99% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -17.81% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -32.62% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -39.32% | — |
Current DrawdownCurrent decline from peak | -2.75% | -1.78% | -0.97% |
Average DrawdownAverage peak-to-trough decline | -2.59% | -10.20% | +7.61% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 4.33% | — |
Volatility
TMED vs. XHS - Volatility Comparison
Loading charts...
Volatility by Period
| TMED | XHS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 4.80% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 11.86% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 18.04% | 17.56% | +0.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.04% | 21.10% | -3.06% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.04% | 22.40% | -4.36% |
TMED vs. XHS - Expense Ratio Comparison
TMED has a 0.44% expense ratio, which is higher than XHS's 0.35% expense ratio.
Dividends
TMED vs. XHS - Dividend Comparison
TMED's dividend yield for the trailing twelve months is around 0.52%, more than XHS's 0.25% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TMED T. Rowe Price Health Care ETF | 0.52% | 0.54% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XHS SPDR S&P Health Care Services ETF | 0.25% | 0.27% | 0.38% | 0.23% | 0.19% | 0.20% | 0.23% | 2.37% | 0.34% | 0.22% | 0.28% | 0.93% |
Frequently Asked Questions
TMED and XHS have a correlation of 0.57, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XHS is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XHS is cheaper with a 0.35% expense ratio, compared with 0.44% for TMED.
TMED has the higher dividend yield at 0.52%, compared with 0.25% for XHS.
They also come from different issuers: T. Rowe Price and State Street. Their fees differ too: 0.44% for TMED and 0.35% for XHS.
Find the right allocation for TMED and XHS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer